EGM
CRBP icon

Engineers Gate Manager’s Corbus Pharmaceuticals CRBP Stock Holding History

Engineers Gate Manager’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Sell
14,200
-2,943
-17% -$24.8K ﹤0.01% 1988
2025
Q4 		$140K Buy
+17,143
New +$212K ﹤0.01% 1860
2025
Q1 		– Sell
-23,037
Closed -$272K – 2224
2024
Q4 		$272K Buy
23,037
+8,151
+55% +$137K ﹤0.01% 1748
2024
Q3 		$307K Buy
+14,886
New +$762K 0.01% 1605
2022
Q1 		– Sell
-670
Closed -$12K – 1921
2021
Q4 		$12K Buy
+670
New +$18.1K ﹤0.01% 1955
2020
Q4 		– Sell
-854
Closed -$46K – 1735
2020
Q3 		$46K Buy
854
+241
+39% +$43.6K ﹤0.01% 1611
2020
Q2 		$154K Buy
613
+163
+36% +$32.9K 0.01% 1507
2020
Q1 		$71K Buy
+450
New +$76.1K 0.01% 1464

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Engineers Gate Manager's CRBP Position: Q1 2026 in Review

Engineers Gate Manager reduced its Corbus Pharmaceuticals (CRBP) stake by 17% in Q1 2026, selling an estimated $24.8K and leaving 14,200 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Engineers Gate Manager first reported a position in CRBP in Q1 2020 and has held it in 8 quarters since. The position peaked at $307K in Q3 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Engineers Gate Manager held 14,200 shares of Corbus Pharmaceuticals worth $133K as of Q1 2026.
  • Engineers Gate Manager sold 2,943 Corbus Pharmaceuticals shares in Q1 2026, an estimated $24.8K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1988 holding.
  • Engineers Gate Manager first reported a position in Corbus Pharmaceuticals in Q1 2020 and has held it in 8 quarters since.
  • Engineers Gate Manager's Corbus Pharmaceuticals position peaked at $307K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.